# Galantamine in the Treatment of Post-Traumatic Headache

> **NCT00219869** · PHASE4 · UNKNOWN · sponsor: **Rapoport, Alan, M.D.** · enrollment: 30 (—)

## Conditions studied

- Post-Traumatic Headache
- Head Trauma,Closed
- Retention Disorders,Cognitive

## Interventions

- **DRUG:** Galantamine

## Key facts

- **NCT ID:** NCT00219869
- **Lead sponsor:** Rapoport, Alan, M.D.
- **Sponsor class:** INDIV
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2005-07
- **Primary completion:** —
- **Final completion:** 2005-08
- **Target enrollment:** 30 (—)
- **Last updated:** 2005-09-22

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00219869

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00219869, "Galantamine in the Treatment of Post-Traumatic Headache". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT00219869. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*